Arcadia Biosciences
(NASDAQ) RKDA
Arcadia Biosciences Financials at a Glance
Market Cap
$2.74M
Revenue (TTM)
$4.86M
Net Income (TTM)
$2.34M
EPS (TTM)
$-1.71
P/E Ratio
-0.78
Dividend
$0.00
Beta (Volatility)
0.88 (Low)
Dividend
$0.00
Beta (Volatility)
0.88 (Low)
Price
$1.35
Volume
368
Open
$1.39
Price
$1.35
Volume
368
Open
$1.39
Previous Close
$1.35
Daily Range
$1.35 - $1.39
52-Week Range
$1.30 - $6.71
Dividend
$0.00
Beta (Volatility)
0.88 (Low)
Price
$1.35
Volume
368
Open
$1.39
Previous Close
$1.35
Daily Range
$1.35 - $1.39
52-Week Range
$1.30 - $6.71
RKDA News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Arcadia Biosciences
Industry
Food Products
Sector
Consumer StaplesEmployees
8
CEO
Thomas J. Schaefer, CFA, MBA
Website
www.arcadiabio.comHeadquarters
Davis, CA 95618, US
RKDA Financials
Key Financial Metrics (TTM)
Gross Margin
36%
Operating Margin
-51%
Net Income Margin
-48%
Return on Equity
-45%
Return on Capital
-56%
Return on Assets
-36%
Earnings Yield
-1.28%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$2.74M
Shares Outstanding
2.06M
Volume
368
Short Interest
0.00%
Avg. Volume
31.61K
Financials (TTM)
Gross Profit
$1.76M
Operating Income
$9.99M
EBITDA
$9.84M
Operating Cash Flow
$4.74M
Capital Expenditure
$0.00
Free Cash Flow
$4.74M
Cash & ST Invst.
$4.56M
Total Debt
$0.00
Arcadia Biosciences Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$901.00K
-25.9%
Gross Profit
$192.00K
-50.6%
Gross Margin
21.31%
N/A
Market Cap
$2.74M
N/A
Market Cap/Employee
$303.97K
N/A
Employees
9
N/A
Net Income
$1.34M
+67.1%
EBITDA
$1.38M
+39.0%
Quarterly Fundamentals
Net Cash
$4.56M
+11.6%
Accounts Receivable
$425.00K
-63.8%
Inventory
$1.21M
+34.1%
Long Term Debt
$0.00
N/A
Short Term Debt
$0.00
-100.0%
Return on Assets
-35.73%
N/A
Return on Invested Capital
-55.67%
N/A
Free Cash Flow
$861.00K
+61.0%
Operating Cash Flow
$861.00K
+61.0%